Your Basket 0

Filter

Applications Product Type Company Conjugate
<<First <Prev    Next> Last>>
Search Results for:
Catalogue No Partner Description Species Application
HY-P9968-1mg MedChemexpress LLC Nimotuzumab [CAS 780758-10-3] Cancer-Kinase/protease
HY-P9968-5mg MedChemexpress LLC Nimotuzumab [CAS 780758-10-3] Cancer-Kinase/protease
HY-P99770-1mg MedChemexpress LLC Omodenbamab [CAS 2241724-48-9] COVID-19-immunoregulation
HY-P99770-10mg MedChemexpress LLC Omodenbamab [CAS 2241724-48-9] COVID-19-immunoregulation
HY-P99770-5mg MedChemexpress LLC Omodenbamab [CAS 2241724-48-9] COVID-19-immunoregulation
HY-P99406-1mg MedChemexpress LLC Petosemtamab [CAS 2213450-26-9] Cancer-Kinase/protease
HY-P99406-10mg MedChemexpress LLC Petosemtamab [CAS 2213450-26-9] Cancer-Kinase/protease
HY-P99406-5mg MedChemexpress LLC Petosemtamab [CAS 2213450-26-9] Cancer-Kinase/protease
HY-P99156-1mg MedChemexpress LLC Relatlimab [CAS 1673516-98-7] Cancer-programmed cell death
HY-P99156-10mg MedChemexpress LLC Relatlimab [CAS 1673516-98-7] Cancer-programmed cell death
HY-P99156-5mg MedChemexpress LLC Relatlimab [CAS 1673516-98-7] Cancer-programmed cell death
HY-P99962-1mg MedChemexpress LLC Surzebiclimab Cancer-programmed cell death
HY-P99962-10mg MedChemexpress LLC Surzebiclimab Cancer-programmed cell death
HY-P99962-5mg MedChemexpress LLC Surzebiclimab Cancer-programmed cell death
HY-P99395-1mg MedChemexpress LLC Talacotuzumab [CAS 1826831-79-1] Cancer-programmed cell death
HY-P99575-1mg MedChemexpress LLC Tarlatamab [CAS 2307488-83-9]
HY-P99575-5mg MedChemexpress LLC Tarlatamab [CAS 2307488-83-9]
HY-P99573-1mg MedChemexpress LLC Tebotelimab [CAS 2245725-04-4] COVID-19-immunoregulation
HY-P99573-10mg MedChemexpress LLC Tebotelimab [CAS 2245725-04-4] COVID-19-immunoregulation
HY-P99573-5mg MedChemexpress LLC Tebotelimab [CAS 2245725-04-4] COVID-19-immunoregulation
HY-P99333-1mg MedChemexpress LLC Volociximab [CAS 558480-40-3] Cancer-programmed cell death
HY-P99333-10mg MedChemexpress LLC Volociximab [CAS 558480-40-3] Cancer-programmed cell death
HY-P99333-5mg MedChemexpress LLC Volociximab [CAS 558480-40-3] Cancer-programmed cell death
HY-P9971-1mg MedChemexpress LLC Camrelizumab [CAS 1798286-48-2] Cancer-programmed cell death
HY-P9971-5mg MedChemexpress LLC Camrelizumab [CAS 1798286-48-2] Cancer-programmed cell death
Address

Insight Biotechnology Limited
PO Box 520
Wembley
Middlesex
HA9 7YN
UK

Contact Us

Tel: 0800 073 3133 (UK)
Fax: 0800 953 0268 (UK)
Tel: +44 20 8385 0303 (International)
Email: Info@insightbio.com

Opening Hours

Monday to Friday- 9am- 5pm

Stay Connected!

@InsightBio

Quick Links

About Us>
Contact Us>
FAQs>
Partners>
Special Offers>
Technical Support>

Created by Purplesheep Internet Limited 2024. © Insight biotechnology. All rights reserved.